Literature DB >> 23985656

Managing malignant melanoma.

William W Dzwierzynski1.   

Abstract

The incidence of melanoma is increasing worldwide. Melanomas represent 3 percent of all skin cancers but 65 percent of skin cancer deaths. Melanoma is now the fifth most common cancer diagnosed in the United States. Excisional biopsy should be performed for lesions suspicious for melanoma. The pathologist's report provides essential information for surgical treatment; the most important information is the Breslow depth of the lesion. In addition to wide surgical excision of the primary lesion, sentinel lymph node biopsy is the standard of care for early identification of regional metastasis. Nodal metastasis found in the sentinel lymph node biopsy should be followed with a complete lymph node dissection. Although surgery remains the primary treatment of melanoma, recent advances in chemotherapy may offer further survival benefits to patients with metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23985656     DOI: 10.1097/PRS.0b013e31829ad411

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

1.  Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.

Authors:  Martin A C Manoukian; Susanne V Ott; Jayakumar Rajadas; Mohammed Inayathullah
Journal:  Recent Pat Nanomed       Date:  2014

2.  Clinical, Dermoscopic and Microscopic Features of a "Collision Tumour" Ultimately Confirmed as a Regressing Melanoma - Lessons Learnt from a Chance Diagnosis.

Authors:  Ioana Mihaela Dogaru; Mariana Costache; Lawrence Chukwudi Nwabudike; Ana Maria Oproiu; Alin Laurentiu Tatu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-13

3.  Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.

Authors:  Tithi Roy; Samuel T Boateng; Sergette Banang-Mbeumi; Pankaj K Singh; Pratik Basnet; Roxane-Cherille N Chamcheu; Federico Ladu; Isabel Chauvin; Vladimir S Spiegelman; Ronald A Hill; Konstantin G Kousoulas; Bolni Marius Nagalo; Anthony L Walker; Jean Fotie; Siva Murru; Mario Sechi; Jean Christopher Chamcheu
Journal:  Bioorg Chem       Date:  2020-12-30       Impact factor: 5.275

Review 4.  STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy.

Authors:  Melanie Spitzner; Reinhard Ebner; Hendrik A Wolff; B Michael Ghadimi; Jürgen Wienands; Marian Grade
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 5.  Controversies in the diagnosis and treatment of early cutaneous melanoma.

Authors:  O A Orzan; A Șandru; C R Jecan
Journal:  J Med Life       Date:  2015 Apr-Jun

6.  Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results-based study.

Authors:  Lianyuan Tao; Haibo Yu; Yadong Dong; Guanjing Tian; Zhiyuan Ren; Deyu Li
Journal:  Cancer Med       Date:  2019-08-13       Impact factor: 4.452

7.  Plantamajoside represses the growth and metastasis of malignant melanoma.

Authors:  Yan Wang; Mingzhu Liu; Shenglan Chen; Qin Wu
Journal:  Exp Ther Med       Date:  2020-01-10       Impact factor: 2.447

8.  Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential.

Authors:  Felix Bürkel; Tina Jost; Markus Hecht; Lucie Heinzerling; Rainer Fietkau; Luitpold Distel
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

9.  Approach to Patients with Malignant Melanoma of Unknown Primary Origin.

Authors:  Selami Serhat Sirvan; Hikmet İhsan Eren; Sevgi Kurt Yazar; Ali Can Günenç; Ayşin Karasoy Yeşilada; Fatih Irmak; Deniz Tuncel
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-03-22

10.  An annotated dataset for extracting gene-melanoma relations from scientific literature.

Authors:  Roberto Zanoli; Alberto Lavelli; Theresa Löffler; Nicolas Andres Perez Gonzalez; Fabio Rinaldi
Journal:  J Biomed Semantics       Date:  2022-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.